NIH LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program The project, funded by NIH and the Louisiana Department of Health, aims to sequence SARS-CoV-2 samples from a range of different patients. NIH Earmarks $38M for Consortium Studying Polygenic Risk Scores in Diverse Populations The consortium aims to develop and evaluate methods for calculating polygenic risk scores for specific diseases, particularly for people of different ancestries. NIH RADx Program Awards $29.3M to Increase SARS-CoV-2 Testing Capacity The contracts are for two lateral flow rapid antigen tests, a laboratory-based test to detect and identify SARS-CoV-2 variants, and a rapid RT-PCR test. Armonica Technologies Wins $349K SBIR Grant From NHGRI he funding will help support product development of a nanopore sequencing-based method of direct DNA analysis, including epigenetic modifications. SARS-CoV-2 Study Implicates Saliva in Viral Transmission Viral entry factors were broadly enriched in the salivary glands and oral mucosae, implicating the oral cavity as an important infection site. Mar 2, 2021 NIH, Partners Commit $74.9M to New Phase of Alzheimer's Program Feb 23, 2021 Phase Genomics Wins $1.7M NIH Grant for Virus Discovery Platform Development Feb 17, 2021 RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing Premium Feb 5, 2021 Meridian Bioscience Fiscal Q1 Revenues Rise 96 Percent Feb 4, 2021 Explosive Detection Device Manufacturer DetectaChem Pivots to SARS-CoV-2 Testing Premium Feb 3, 2021 Meridian Bioscience Receives $5.5M From NIH to Expand SARS-CoV-2 Test Production Jan 7, 2021 Meridian Bioscience Preliminary Fiscal 2021 Q1 Revenues Up 94 Percent Dec 28, 2020 President Trump Signs FY 2021 Spending Bill to Boost NIH Budget 3 Percent Dec 22, 2020 Congress Approves 3 Percent Increase in NIH Budget for Fiscal 2021 Dec 16, 2020 Meridian Bioscience Receives $1M NIH Grant for SARS-CoV-2 Test Launch Dec 10, 2020 All of Us Program Returns First Genetic Results; Health-Related Finding to Follow in Late 2021 Premium Dec 9, 2020 Day Zero Diagnostics Wins $300K NIH Grant to Refine HAI Outbreak Analysis Service Nov 5, 2020 Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing Oct 29, 2020 Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company Oct 16, 2020 NIH Kicks Off Second Stage of 4D Nucleome Program With $142M in Research Grants Oct 6, 2020 RAD-X Awards Six Phase 2 Contracts for COVID-19 Testing Oct 6, 2020 Startup Coral Genomics Wins $2M SBIR Grant From NIH Oct 1, 2020 DiamiR Wins $3.9M in NIH Funding for Neurological Disease Diagnostic Development Sep 29, 2020 Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production Sep 9, 2020 Visby Medical Takes on STI, COVID-19 Testing With Single-Use PCR Machine Premium Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.